Forget Zepbound: Eli Lilly’s Next Billion-Dollar Weight-Loss Drug May Be Even Better
Eli Lilly (NYSE: LLY) has been posting incredible sales and earnings growth in recent quarters, thanks in no…
Pharmacy ordered to recall unregistered weight-loss medicines after raid
THE South African Health Products Regulatory Authority (SAHPRA) and the South African Pharmacy Council (SAPC) have launched a…